Active ingredients: Bazedoxifene
CONBRIZA 20 mg film-coated tablets.
Film-coated tablet.
White to off-white, capsule-shaped, film-coated tablet debossed on one side with “WY20”. The tablet is approximately 1.5 cm in length.
Each film-coated tablet contains bazedoxifene acetate equivalent to 20 mg bazedoxifene.
Excipient with known effect: Each film-coated tablet contains 142.8 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
Tablet core:
Lactose monohydrate
Microcrystalline cellulose
Pregelatinised starch (maize)
Sodium starch glycolate
Sodium lauryl sulfate
Colloidal anhydrous silica
Magnesium stearate
Ascorbic acid
Film coating:
Hypromellose
Titanium dioxide (E171)
Macrogol 400
PVC/Aclar blister packs of 7, 28, 30, 84, and 90 film-coated tablets.
Not all pack sizes may be marketed.
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050, Bruxelles, Belgium
EU/1/09/511/001
EU/1/09/511/002
EU/1/09/511/003
EU/1/09/511/004
EU/1/09/511/005
Date of first authorisation: 17 April 2009
Date of latest renewal: 17 April 2014